Journals / Respiratory Case Reports / 2019 / Cilt: 8 - Sayı: 1

Minimal Change Disease and Bilateral Nonarteritic Ischemic Optic Neuropathy in a Patient with Pleural Mesothelioma

Plevral Mezotelyomalı Bir Hastada Bilateral Non-arteritik İskemik Optik Nöropati ve Minimal Değişiklik Hastalığı

Pages
21–25
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Further investigation revealed pleural mesothelioma.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Malignant mesothelioma typically presents with slowlyprogressive dyspnea and chest pain.
📊
Key Findings & Data:The present report describes the case of a65-year-old man with a remote occupational exposure to asbestos more than 26 years prior who presented with a month’s history of slowly progressivevisual loss, minimal weight loss, and pedal edema.Assessments by several ophthalmologists concludedthat he had developed non-arteritic ischemic opticneuropathy.
💡
Conclusion & Impact:Further investigation revealed pleural mesothelioma.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Malignant mesothelioma typically presents with slowlyprogressive dyspnea and chest pain. Extra-thoracicsymptoms and paraneoplastic presentations are veryrare. The association of this malignancy with glomerular disorders has been only rarely reported in theliterature. The present report describes the case of a65-year-old man with a remote occupational exposure to asbestos more than 26 years prior who presented with a month’s history of slowly progressivevisual loss, minimal weight loss, and pedal edema.Assessments by several ophthalmologists concludedthat he had developed non-arteritic ischemic opticneuropathy. Further nephrological work-up demonstrated that he had developed nephrotic syndromedue to minimal change disease, which was confirmedwith a renal biopsy. His clinical symptoms rapidlyimproved with steroid treatment. The nephrotic syndrome went into clinical remission, his progressivevisual loss improved, and there was no further weightloss. The initial chest X-ray performed when he firstpresented was reported as showing only chronicchanges. He reported the symptoms of shortness ofbreath and chest pain 8 months later and was foundto have a large right pleural effusion. Further investigation revealed pleural mesothelioma.

Özet

Malign mezotelyoma tipik olarak yavaş ilerleyen dispne ve göğüs ağrısı ile kendini göstermektedir. Toraks dışı semptomlar ve paraneoplastik tablolar çok nadirdir. Bu maliginite ile glomerüler hastalık birlikteliği literatürde nadiren bildirilmiştir. Bu olgu sunumunda, 26 yıl önce mesleksel asbest maruziyeti olan son bir aydır yavaş ilerleyen görme kaybı, hafif kilo kaybı ve ayaklarda ödem yakınmaları olan 65 yaşında erkek hasta sunulmuştur. Göz hastalıkları uzmanları tarafından non-arteritik iskemik optik nöropati geliştiği belirlendi. İleri nefrolojik incelemelerde renal biyopsi ile doğrulanan minimal değişiklik hastalığına bağlı nefrotik sendrom olduğu gösterildi. Steroid tedavisi ile klinik semptomlar hızla düzeldi. Nefrotik sendrom ve ilerleyici görme kaybı klinik olarak remisyona girdi ve kilo kaybı düzeldi. Başlangıç akciğer grafisi yalnızca kronik değişiklikler gösteriyordu. Sekiz ay sonra nefes darlığı ve göğüs ağrısı semptomları ortaya çıktı ve sağ da yoğun plevral sıvı saptandı. İleri incelemelerde plevral mezotelyoma tespit edildi.

🔖

Cite This Article

Tagboto, S. (2022). Minimal Change Disease and Bilateral Nonarteritic Ischemic Optic Neuropathy in a Patient with Pleural Mesothelioma. Respiratory Case Reports, Cilt: 8 - Sayı: 1, 21–25. https://ajindex.com/articles/588958

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Robinson BW, Lake RA. Advances in malignant mesothelioma. N Engl J Med 2005; 353:1591–603. [CrossRef] 2. Bianchi C, Giarelli L, Grandi G, Brollo A, Ramani L, Zuch C. Latency periods in asbestos-related mesothelioma of the pleura. Eur J Cancer Prev 1997; 62:162–6. 3. Blyth KG, Murphy DJ. Progress and challenges in mesothelioma: from bench to bedside. Respir Med 2018; 134:31-41. [CrossRef] 4. Sun HH, Vaynblat A, Pass HI. Diagnosis and prognosisreview of biomarkers for mesothelioma. Ann Transl Med 2017; 5:244. [CrossRef] 5. Vogelzang NJ, Rusthoven JJ, Symanowski J, Denham C, Kaukel E, Ruffie P, et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 2003; 21:2636–44. [CrossRef] 6. Zalcman G, Mazieres J, Margery J, Greillier L, AudigierValette C, Moro-Sibilot D, et al. Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial. Lancet 2016; 387:1405–14. [CrossRef] 7. van Zandwijk N, Clarke C, Henderson D, Musk AW, Fong K, Nowak A, et al. Guidelines for the diagnosis and treatment of malignant pleural mesothelioma. J Thorac Dis 2013; 5:E254–E307. [CrossRef] 8. Wolf AS, Daniel J, Sugarbaker DJ. Surgical techniques for multimodality treatment of malignant pleural mesothelioma: extrapleural pneumonectomy and pleurectomy/decortication. Semin Thorac Cardiovasc Surg 2009; 212:132–48. [CrossRef] 9. Ahmed M, Solangi K, Abbi R, Adler S. Nephrotic syndrome, renal failure, and renal malignancy: an unusual tumor associated glomerulonephritis. J Am Soc Nephrol 1997; 8:848–52. 10. Farmer CK, Goldsmith DJ. Nephrotic syndrome and mesenteric infarction secondary to metastatic mesothelioma. Postgrad Med J 2001; 77:333–4. [CrossRef] 11. Pu X, Dou Y, Liu D, Lu S, Quan S, Zhang X, Ma S, Zhao Z. Membranous nephropathy associated with malignant pleural mesothelioma in an adult patient: A case report. Mol Clin Oncol 2016; 5:407-10. [CrossRef] 12. Schroeter NJ, Rushing DA, Parker JP, Beltaos E. Minimalchange nephrotic syndrome associated with malignant mesothelioma. Arch Intern Med 1986; 146:1834–6. [CrossRef] 13. Tanaka S, Oda H, Satta H, Takizawa T, Tochikubo O, Takagi N, et al. Nephrotic syndrome associated with malignant mesothelioma. Nephron 1994; 67:510–1. [CrossRef]